Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID-19: A population-based study

被引:10
|
作者
Zhou, Jiandong [1 ]
Tse, Gary
Lee, Sharen [2 ]
Liu, Tong [3 ]
Cao, Zhidong [4 ]
Zeng, Daniel Dajun [4 ]
Leung, Keith Sai Kit [5 ]
Wai, Abraham Ka Chung [5 ]
Wong, Ian Chi Kei [6 ,7 ]
Cheung, Bernard Man Yung [8 ]
Zhang, Qingpeng [1 ]
机构
[1] City Univ Hong Kong, Sch Data Sci, Hong Kong, Peoples R China
[2] Tianjin Med Univ, Second Hosp, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Dept Cardiol,Tianjin Inst Cardiol, Tianjin, Peoples R China
[3] Li Ka Shing Inst Hlth Sci, Lab Cardiovasc Physiol, Cardiovasc Analyt Grp, Hong Kong, Peoples R China
[4] Chinese Acad Sci, Inst Automat, Beijing, Beijing, Peoples R China
[5] Univ Hong Kong, Emergency Med Unit, Hong Kong, Peoples R China
[6] Univ Hong Kong, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China
[7] UCL, Med Optimisat Res & Educ CMORE, Sch Pharm, London, England
[8] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China
关键词
D O I
10.1002/jmv.26904
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:2635 / 2641
页数:7
相关论文
共 50 条
  • [21] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [22] Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
    Wenjun Wang
    Xiaohui Zhao
    Wei Wei
    Weiwang Fan
    Kai Gao
    Shengxiu He
    Xijing Zhuang
    BMC Infectious Diseases, 21
  • [23] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [24] Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
    Mamdani, Muhammad
    Gomes, Tara
    Greaves, Simon
    Manji, Selina
    Juurlink, David N.
    Tadrous, Mina
    Kennedy, Sidney H.
    Antoniou, Tony
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [25] The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality
    Mourad, Jean-Jacques
    MAYO CLINIC PROCEEDINGS, 2016, 91 (07) : 972 - 972
  • [26] COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. Scientific brief
    不详
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 120 - 121
  • [27] Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study
    Hakeam, Hakeam A.
    Alsemari, Muhannad
    Al Duhailib, Zainab
    Ghonem, Leen
    Alharbi, Saad A.
    Almutairy, Eid
    Bin Sheraim, Nader M.
    Alsalhi, Meshal
    Alhijji, Ali
    AlQahtani, Sara
    Khalid, Mohammed
    Barry, Mazin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (03) : 244 - 252
  • [28] Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
    Mortensen, Eric M.
    Nakashima, Brandy
    Cornell, John
    Copeland, Laurel A.
    Pugh, Mary Jo
    Anzueto, Antonio
    Good, Chester
    Restrepo, Marcos I.
    Downs, John R.
    Frei, Christopher R.
    Fine, Michael J.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (11) : 1466 - 1473
  • [29] Comparative Effectiveness between Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on Mortality: a Nationwide, Population-based, Prospective Cohort Study in China
    Wang, Yunfeng
    Guo, Weihong
    Hao, Yang
    Zheng, Xin
    Zhang, Haibo
    Yang, Yang
    Chen, Bowang
    Zhang, Xiaoyan
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Wang, Chunqi
    Wu, Yi
    Krumholz, Harlan
    Li, Xi
    Hu, Shengshou
    HYPERTENSION, 2024, 81
  • [30] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers benefits outweigh the risks in COVID-19 hypertensive patients
    Ateya, Areej Mohamed
    Sabri, Nagwa A.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1873 - 1874